Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Market Analysis and Insights: Global Nitric Oxide Therapy System Market
The global Nitric Oxide Therapy System market is projected to grow from US$ 34 million in 2024 to US$ 46 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.
Report Covers:
This report presents an overview of global market for Nitric Oxide Therapy System market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Nitric Oxide Therapy System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nitric Oxide Therapy System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nitric Oxide Therapy System revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Nitric Oxide Therapy System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Nitric Oxide Therapy System revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Segment by Type
Protable System
Fixed System
Segment by Application
Hospitals
Homecare Settings
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Nitric Oxide Therapy System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nitric Oxide Therapy System companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nitric Oxide Therapy System revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nitric Oxide Therapy System Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Protable System
1.2.3 Fixed System
1.3 Market by Application
1.3.1 Global Nitric Oxide Therapy System Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nitric Oxide Therapy System Market Perspective (2019-2030)
2.2 Global Nitric Oxide Therapy System Growth Trends by Region
2.2.1 Nitric Oxide Therapy System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nitric Oxide Therapy System Historic Market Size by Region (2019-2024)
2.2.3 Nitric Oxide Therapy System Forecasted Market Size by Region (2025-2030)
2.3 Nitric Oxide Therapy System Market Dynamics
2.3.1 Nitric Oxide Therapy System Industry Trends
2.3.2 Nitric Oxide Therapy System Market Drivers
2.3.3 Nitric Oxide Therapy System Market Challenges
2.3.4 Nitric Oxide Therapy System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nitric Oxide Therapy System by Players
3.1.1 Global Nitric Oxide Therapy System Revenue by Players (2019-2024)
3.1.2 Global Nitric Oxide Therapy System Revenue Market Share by Players (2019-2024)
3.2 Global Nitric Oxide Therapy System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nitric Oxide Therapy System, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Nitric Oxide Therapy System Market Concentration Ratio
3.4.1 Global Nitric Oxide Therapy System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nitric Oxide Therapy System Revenue in 2023
3.5 Global Key Players of Nitric Oxide Therapy System Head office and Area Served
3.6 Global Key Players of Nitric Oxide Therapy System, Product and Application
3.7 Global Key Players of Nitric Oxide Therapy System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nitric Oxide Therapy System Breakdown Data by Type
4.1 Global Nitric Oxide Therapy System Historic Market Size by Type (2019-2024)
4.2 Global Nitric Oxide Therapy System Forecasted Market Size by Type (2025-2030)
5 Nitric Oxide Therapy System Breakdown Data by Application
5.1 Global Nitric Oxide Therapy System Historic Market Size by Application (2019-2024)
5.2 Global Nitric Oxide Therapy System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nitric Oxide Therapy System Market Size (2019-2030)
6.2 North America Nitric Oxide Therapy System Market Size by Type
6.2.1 North America Nitric Oxide Therapy System Market Size by Type (2019-2024)
6.2.2 North America Nitric Oxide Therapy System Market Size by Type (2025-2030)
6.2.3 North America Nitric Oxide Therapy System Market Share by Type (2019-2030)
6.3 North America Nitric Oxide Therapy System Market Size by Application
6.3.1 North America Nitric Oxide Therapy System Market Size by Application (2019-2024)
6.3.2 North America Nitric Oxide Therapy System Market Size by Application (2025-2030)
6.3.3 North America Nitric Oxide Therapy System Market Share by Application (2019-2030)
6.4 North America Nitric Oxide Therapy System Market Size by Country
6.4.1 North America Nitric Oxide Therapy System Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Nitric Oxide Therapy System Market Size by Country (2019-2024)
6.4.3 North America Nitric Oxide Therapy System Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nitric Oxide Therapy System Market Size (2019-2030)
7.2 Europe Nitric Oxide Therapy System Market Size by Type
7.2.1 Europe Nitric Oxide Therapy System Market Size by Type (2019-2024)
7.2.2 Europe Nitric Oxide Therapy System Market Size by Type (2025-2030)
7.2.3 Europe Nitric Oxide Therapy System Market Share by Type (2019-2030)
7.3 Europe Nitric Oxide Therapy System Market Size by Application
7.3.1 Europe Nitric Oxide Therapy System Market Size by Application (2019-2024)
7.3.2 Europe Nitric Oxide Therapy System Market Size by Application (2025-2030)
7.3.3 Europe Nitric Oxide Therapy System Market Share by Application (2019-2030)
7.4 Europe Nitric Oxide Therapy System Market Size by Country
7.4.1 Europe Nitric Oxide Therapy System Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Nitric Oxide Therapy System Market Size by Country (2019-2024)
7.4.3 Europe Nitric Oxide Therapy System Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nitric Oxide Therapy System Market Size (2019-2030)
8.2 China Nitric Oxide Therapy System Market Size by Type
8.2.1 China Nitric Oxide Therapy System Market Size by Type (2019-2024)
8.2.2 China Nitric Oxide Therapy System Market Size by Type (2025-2030)
8.2.3 China Nitric Oxide Therapy System Market Share by Type (2019-2030)
8.3 China Nitric Oxide Therapy System Market Size by Application
8.3.1 China Nitric Oxide Therapy System Market Size by Application (2019-2024)
8.3.2 China Nitric Oxide Therapy System Market Size by Application (2025-2030)
8.3.3 China Nitric Oxide Therapy System Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Nitric Oxide Therapy System Market Size (2019-2030)
9.2 Asia Nitric Oxide Therapy System Market Size by Type
9.2.1 Asia Nitric Oxide Therapy System Market Size by Type (2019-2024)
9.2.2 Asia Nitric Oxide Therapy System Market Size by Type (2025-2030)
9.2.3 Asia Nitric Oxide Therapy System Market Share by Type (2019-2030)
9.3 Asia Nitric Oxide Therapy System Market Size by Application
9.3.1 Asia Nitric Oxide Therapy System Market Size by Application (2019-2024)
9.3.2 Asia Nitric Oxide Therapy System Market Size by Application (2025-2030)
9.3.3 Asia Nitric Oxide Therapy System Market Share by Application (2019-2030)
9.4 Asia Nitric Oxide Therapy System Market Size by Region
9.4.1 Asia Nitric Oxide Therapy System Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Nitric Oxide Therapy System Market Size by Region (2019-2024)
9.4.3 Asia Nitric Oxide Therapy System Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Nitric Oxide Therapy System Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bellerophon Therapeutics
11.1.1 Bellerophon Therapeutics Company Details
11.1.2 Bellerophon Therapeutics Business Overview
11.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Introduction
11.1.4 Bellerophon Therapeutics Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.1.5 Bellerophon Therapeutics Recent Developments
11.2 BOC Healthcare
11.2.1 BOC Healthcare Company Details
11.2.2 BOC Healthcare Business Overview
11.2.3 BOC Healthcare Nitric Oxide Therapy System Introduction
11.2.4 BOC Healthcare Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.2.5 BOC Healthcare Recent Developments
11.3 Dan Hammer Health
11.3.1 Dan Hammer Health Company Details
11.3.2 Dan Hammer Health Business Overview
11.3.3 Dan Hammer Health Nitric Oxide Therapy System Introduction
11.3.4 Dan Hammer Health Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.3.5 Dan Hammer Health Recent Developments
11.4 EKU Elektronik GmbH
11.4.1 EKU Elektronik GmbH Company Details
11.4.2 EKU Elektronik GmbH Business Overview
11.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Introduction
11.4.4 EKU Elektronik GmbH Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.4.5 EKU Elektronik GmbH Recent Developments
11.5 GeNO LLC
11.5.1 GeNO LLC Company Details
11.5.2 GeNO LLC Business Overview
11.5.3 GeNO LLC Nitric Oxide Therapy System Introduction
11.5.4 GeNO LLC Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.5.5 GeNO LLC Recent Developments
11.6 International Biomedical
11.6.1 International Biomedical Company Details
11.6.2 International Biomedical Business Overview
11.6.3 International Biomedical Nitric Oxide Therapy System Introduction
11.6.4 International Biomedical Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.6.5 International Biomedical Recent Developments
11.7 SLE
11.7.1 SLE Company Details
11.7.2 SLE Business Overview
11.7.3 SLE Nitric Oxide Therapy System Introduction
11.7.4 SLE Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.7.5 SLE Recent Developments
11.8 Mallinckrodt Pharmaceuticals
11.8.1 Mallinckrodt Pharmaceuticals Company Details
11.8.2 Mallinckrodt Pharmaceuticals Business Overview
11.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Introduction
11.8.4 Mallinckrodt Pharmaceuticals Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.8.5 Mallinckrodt Pharmaceuticals Recent Developments
11.9 Praxair,
11.9.1 Praxair, Company Details
11.9.2 Praxair, Business Overview
11.9.3 Praxair, Nitric Oxide Therapy System Introduction
11.9.4 Praxair, Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.9.5 Praxair, Recent Developments
11.10 Vapotherm
11.10.1 Vapotherm Company Details
11.10.2 Vapotherm Business Overview
11.10.3 Vapotherm Nitric Oxide Therapy System Introduction
11.10.4 Vapotherm Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.10.5 Vapotherm Recent Developments
11.11 Linde Group
11.11.1 Linde Group Company Details
11.11.2 Linde Group Business Overview
11.11.3 Linde Group Nitric Oxide Therapy System Introduction
11.11.4 Linde Group Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.11.5 Linde Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
听
听
*If Applicable.
